Viracta Therapeutics Pink Sheet Forecast - Accumulation Distribution

VIRXDelisted Stock  USD 0.03  0  7.38%   
Viracta Pink Sheet Forecast is based on your current time horizon.
  
Viracta Therapeutics has current Accumulation Distribution of 0.28. The accumulation distribution (A/D) indicator shows the degree to which Viracta Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Viracta Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Viracta Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.
Check Viracta Therapeutics VolatilityBacktest Viracta TherapeuticsInformation Ratio  

Viracta Therapeutics Trading Date Momentum

On February 26 2025 Viracta Therapeutics was traded for  0.03  at the closing time. The top price for the day was 0.04  and the lowest listed price was  0.03 . There was no trading activity during the period 0.0. Lack of trading volume on February 26, 2025 did not result in any price rise and fall. The trading price change against the current closing price is 7.97% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Viracta Therapeutics to competition

View Viracta Therapeutics Related Equities

 Risk & Return  Correlation

Viracta Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Viracta Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Viracta Therapeutics shares will generate the highest return on investment. By undertsting and applying Viracta Therapeutics pink sheet market strength indicators, traders can identify Viracta Therapeutics entry and exit signals to maximize returns.

Viracta Therapeutics Risk Indicators

The analysis of Viracta Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Viracta Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting viracta pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Viracta Pink Sheet

If you are still planning to invest in Viracta Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viracta Therapeutics' history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes